The effect of gonadotropin agonist on uterine myoma

Not Applicable

• Conditions: Submucous leiomyoma of uterus; leiomyoma of uterus.

• Registration Number: IRCT2017111423949N6
• Lead Sponsor: Vice chancellor for research, Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: Female
• Target Recruitment: 46

Inclusion Criteria

Entry Requirements: Patients with abnormal hemorrhage present in a submucosal ultrasonography referring to the clinic of the Rasoul Hospital and who are candidates for myomectomy hysteroscopy are included in the study.
Exclusion criteria:Thyroid disease; Cancer history; Coagulation disorders; Abnormal pap smear; vascular disease; High prolactin

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Recurrence uterine myoma. Timepoint: pre operation and 3 m after operation. Method of measurement: ultrasonography.

Secondary Outcome Measures

Name	Time	Method
Hemoglubin drop. Timepoint: preoperation and 6 hours after operation. Method of measurement: CBC.